XML 156 R130.htm IDEA: XBRL DOCUMENT v3.3.0.814
(Schedule of Reconciliation of Changes in Fair Value of Contingent Consideration) (Details) - Recurring - Contingent Consideration - Questcor Pharmaceuticals, Inc.
$ in Millions
12 Months Ended
Sep. 25, 2015
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Beginning balance $ 202.8
Payments (29.0)
Business Combination, Contingent Consideration, Accretion 7.5
Effect of currency rate change (6.7)
Ending balance $ 174.6